Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.
about
Pharmaceutical policies: effects of sales and dispensing policiesInfluence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.Systematic review on quality control for drug management programs: is quality reported in the literature?A comparison of drug formularies and the potential for cost-savingsPhysicians' generic drug prescribing behavior in district hospitals: a case of Phitsanulok, Thailand.Tribute to John M. EisenbergAssociation of income and prescription drug coverage with generic medication use among older adults with hypertensionBeliefs about generic drugs among elderly adults in hospital-based primary care practicesBrand name and generic proton pump inhibitor prescriptions in the United States: insights from the national ambulatory medical care survey (2006-2010).What's in a name? Use of brand versus generic drug names in United States outpatient practice.Sources of regional variation in Medicare Part D drug spending.Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study.Use of fibrates in the United States and CanadaThe rise of the generic drug market and its implications for dermatology.Perception and attitude of physicians toward local generic medicines in Saudi Arabia: A questionnaire-based study.Clinical outcomes after conversion from brand-name tacrolimus (prograf) to a generic formulation in renal transplant recipients: a retrospective cohort studyFirm- and drug-specific patterns of generic drug payments by US medicaid programs: 1991-2008.The impact of South Korea's new drug-pricing policy on market competition among off-patent drugs.Patterns and predictors of generic narrow therapeutic index drug use among older adults.Pharmaceutical speakers' bureaus, academic freedom, and the management of promotional speaking at academic medical centers.Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.Perceptions and behaviors of patients and pharmacists towards generic drug substitution in Lebanon.Medicaid Expenditures and Estimated Rebates for Epinephrine Autoinjectors, 2012 to 2016.
P2860
Q24188073-CE07C0A4-2FF0-4BE6-B2B4-573B3307EEADQ33321951-4755B740-EC2E-4976-B725-2A88DC4EF980Q33412577-03F4169F-8EAA-4279-B51D-891CB2AFD324Q33932469-0278DA04-CAEB-4E24-B481-031AC9C7C645Q34021635-4D7E28B6-C662-4F14-82F7-7C2D762A9D31Q34335932-EFC7C053-B546-4B2D-99A8-F06350AB993DQ34552299-0061D10D-1F4C-4553-93E7-F1C972651911Q34809382-C717B8C7-A0E9-48E5-810E-F17678372692Q35102825-08E4A3F8-728A-4E30-8827-C7F7A375E58DQ35753043-67395E4C-AA4C-482E-8B7D-A51BA8741109Q35773656-E6A295B0-96B5-4CA6-90C9-7FB85B5C8C2EQ35859096-D556A711-5457-42B2-9722-995E148301A4Q35903762-588E0CD0-515D-4142-90CC-B69D827E53DBQ36374579-335235F8-7C69-48D0-AA34-CBEFC931CAA9Q36806877-B1750D0A-6B37-4CAE-BD44-028774C039F7Q37271349-620C13DD-0B92-40E8-A691-CC05207CC3C4Q39211643-1846E91D-5088-40FE-BDEA-9AD50D5F956BQ40513945-BC8C8F07-0D3B-43F4-ABB8-EBD66EE8ABB1Q44404472-1F691428-DBB8-467F-BED0-E91F42DB44A6Q47575620-DB46445C-9B18-471D-9E88-543349D17D8AQ47998668-BC98EFEF-FA17-464F-B1DA-2BB847B05776Q53551713-976A2565-26C1-475E-BC6C-78AA3A72958FQ55323829-1C26768D-A4D8-4140-8754-25FDE3741D02
P2860
Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Economic consequences of under ...... escription drug benefit plans.
@ast
Economic consequences of under ...... escription drug benefit plans.
@en
Economic consequences of under ...... escription drug benefit plans.
@nl
type
label
Economic consequences of under ...... escription drug benefit plans.
@ast
Economic consequences of under ...... escription drug benefit plans.
@en
Economic consequences of under ...... escription drug benefit plans.
@nl
prefLabel
Economic consequences of under ...... escription drug benefit plans.
@ast
Economic consequences of under ...... escription drug benefit plans.
@en
Economic consequences of under ...... escription drug benefit plans.
@nl
P2860
P356
P1476
Economic consequences of under ...... escription drug benefit plans.
@en
P2093
Jerry Avorn
Michael A Fischer
P2860
P304
P356
10.1111/1475-6773.00162
P577
2003-08-01T00:00:00Z